James Daniel Kish - Director at Sunshine Biopharma Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SBFM, SBFMW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Daniel Kish since 11 Mar 2025

Holdings reported by James Daniel Kish for Sunshine Biopharma Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 287,100 $219,201 $0.7635 31 Oct 2021 Direct
Common Stock 2,500 $1,909 $0.7635 31 Oct 2021 Held in the name of Reporting Person's Spouse

There are no transactions reported by James Daniel Kish for Sunshine Biopharma Inc.